In the past week, RMTI stock has gone down by -11.41%, with a monthly decline of -32.66% and a quarterly plunge of -21.28%. The volatility ratio for the week is 9.54%, and the volatility levels for the last 30 days are 9.66% for Rockwell Medical Inc The simple moving average for the past 20 days is -32.61% for RMTI’s stock, with a 1.48% simple moving average for the past 200 days.
Is It Worth Investing in Rockwell Medical Inc (NASDAQ: RMTI) Right Now?
Additionally, the 36-month beta value for RMTI is 1.45. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 1 rating it as “hold,” and 1 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for RMTI is 28.29M and currently, short sellers hold a 3.16% ratio of that float. The average trading volume of RMTI on November 21, 2024 was 780.83K shares.
RMTI) stock’s latest price update
The stock price of Rockwell Medical Inc (NASDAQ: RMTI) has dropped by -6.43 compared to previous close of 2.49. Despite this, the company has seen a fall of -11.41% in its stock price over the last five trading days. businesswire.com reported 2024-11-19 that WIXOM, Mich.–(BUSINESS WIRE)—- $RMTI #EndStageKidneyDisease–Rockwell Medical will be the exclusive supplier of all dry hemodialysis concentrates products to Nephro Group.
Analysts’ Opinion of RMTI
Many brokerage firms have already submitted their reports for RMTI stocks, with Rodman & Renshaw repeating the rating for RMTI by listing it as a “Buy.” The predicted price for RMTI in the upcoming period, according to Rodman & Renshaw is $5 based on the research report published on November 14, 2024 of the current year 2024.
Piper Jaffray, on the other hand, stated in their research note that they expect to see RMTI reach a price target of $10. The rating they have provided for RMTI stocks is “Overweight” according to the report published on June 24th, 2019.
H.C. Wainwright gave a rating of “Buy” to RMTI, setting the target price at $11 in the report published on May 13th of the previous year.
RMTI Trading at -35.26% from the 50-Day Moving Average
After a stumble in the market that brought RMTI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -54.76% of loss for the given period.
Volatility was left at 9.66%, however, over the last 30 days, the volatility rate increased by 9.54%, as shares sank -33.24% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -43.17% lower at present.
During the last 5 trading sessions, RMTI fell by -11.41%, which changed the moving average for the period of 200-days by +84.92% in comparison to the 20-day moving average, which settled at $3.46. In addition, Rockwell Medical Inc saw 23.28% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RMTI starting from RAVICH MARK H, who sale 19,991 shares at the price of $2.32 back on Nov 15 ’24. After this action, RAVICH MARK H now owns 0 shares of Rockwell Medical Inc, valued at $46,379 using the latest closing price.
RAVICH MARK H, the Director of Rockwell Medical Inc, sale 10,000 shares at $2.40 during a trade that took place back on Nov 15 ’24, which means that RAVICH MARK H is holding 121,429 shares at $24,000 based on the most recent closing price.
Stock Fundamentals for RMTI
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 0.17 for the gross margin
The net margin for Rockwell Medical Inc stands at -0.01. The total capital return value is set at 0.01. Equity return is now at value -6.03, with -2.78 for asset returns.
Based on Rockwell Medical Inc (RMTI), the company’s capital structure generated 0.23 points at debt to capital in total, while cash flow to debt ratio is standing at 0.37. The debt to equity ratio resting at 0.3. The interest coverage ratio of the stock is 0.28.
Currently, EBITDA for the company is -4.69 million with net debt to EBITDA at -0.26. When we switch over and look at the enterprise to sales, we see a ratio of 0.75. The receivables turnover for the company is 11.13for trailing twelve months and the total asset turnover is 1.73. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.41.
Conclusion
In conclusion, Rockwell Medical Inc (RMTI) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
